Welcome to our dedicated page for Scworx SEC filings (Ticker: WORX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering where to find the next clue about SCWorx’s hospital-data SaaS growth? Every answer hides inside the company’s SEC disclosures—from its sprawling annual report to a single Form 4 insider sale. Stock Titan’s AI engine turns those dense documents into plain-English insights, so you can move from reading to decision-making in minutes.
Start with the SCWorx annual report 10-K simplified: our summaries highlight subscription revenue trends, R&D spend on data-interoperability modules, and any HIPAA compliance risks. Need fresh numbers? The SCWorx quarterly earnings report 10-Q filing is parsed instantly, letting you track hospital-contract renewals without digging through footnotes. Sudden developments arrive via SCWorx 8-K material events explained, while the proxy reveals executive pay structures in the SCWorx proxy statement executive compensation.
- SCWorx insider trading Form 4 transactions delivered in real time—monitor buying or selling before it moves the tape.
- SCWorx Form 4 insider transactions real-time alerts directly to your dashboard or inbox.
- AI-driven “what-it-means” notes for every footnote—understanding SCWorx SEC documents with AI has never been easier.
Whether you’re running an earnings-model or screening micro-cap healthcare IT names, our platform answers the questions investors actually ask: “How do I read SCWorx’s 10-K?” “Is there a new financing 8-K?” “Where are SCWorx executive stock transactions Form 4 listed?” With comprehensive coverage, real-time updates from EDGAR, and AI that spots the metrics that matter, SCWorx SEC filings explained simply becomes more than a promise—it’s your new workflow.
SCWorx Corp. set its annual meeting for December 8, 2025 to vote on eight proposals, including director elections, an advisory say‑on‑pay, and ratification of Astra Audit & Advisory, LLC as auditor. The record date is October 10, 2025.
Key capital items seek approval under Nasdaq Rule 5635(d): (1) issuance upon exercise of January 2025 Private Investment Warrants, covering 21,988,638 shares at a $0.3496 exercise price with 4.99%/9.99% beneficial ownership limits; (2) a September 17, 2025 warrant inducement creating 4,128,000 Reload Warrants at $0.31004 after cash exercise of 2,064,000 existing warrants at $0.3496; and (3) a Future Offering of up to $1.5 million in senior secured convertible notes (maximum 6,250,000 conversion shares) and warrants initially exercisable for up to 30,000,000 shares.
Shareholders will also vote to increase authorized common stock from 45,000,000 to 150,000,000 and adopt a 2025 Equity Incentive Plan reserving 10,000,000 shares. Common shares outstanding were 12,105,650 as of October 10, 2025.
SCWorx Corp. (WORX) received a 180-day Nasdaq extension to regain bid-price compliance and now has until April 6, 2026 to meet the $1.00 minimum under Nasdaq Rules 5550(a)(2) and 5810(c)(3)(A). The company will be deemed compliant if its common stock closes at $1.00 or more for at least 10 consecutive business days before that date.
SCWorx states it is monitoring its share price and, if compliance is not regained within the extension, it plans to implement a reverse stock split previously approved by shareholders. If compliance is still not achieved, Nasdaq may issue a delisting notice, which the company could appeal to a hearings panel. The extension has no immediate effect on trading; shares continue on the Nasdaq Capital Market under the symbol WORX.
SCWorx Corp. filed a Form D reporting a completed Regulation D private offering under Rule 506(b). The company, a Delaware corporation with principal offices in Tampa, FL, offered equity and related options/warrants and reports a total offering amount of $721,574, with $721,574 sold and $0 remaining. The filing notes proceeds include $0.3496 per share received upon sale of warrants. The offering was new (first sale on 2025-09-17), closed to last more than one year, accepted a $0 minimum investment, and lists 4 investors to date. The issuer claimed no sales commissions or finders’ fees and disclosed $0 set aside specifically for payments to named officers or directors.
SCWorx Corp. reported a six-month decline in revenue to $1,402,931 from $1,554,126 a year earlier and a widened net loss of $2,382,388 versus $515,972, driven largely by significant non-cash interest and debt discount amortization related to new convertible financings.
The balance sheet shows $340,209 in cash, $412,216 of net accounts receivable and total assets of $6,645,933. Accumulated deficit totaled $33,358,454 and deferred revenue was $219,250. During the period the company issued aggregate convertible notes of $2,655,000 and recognized substantial amortization of debt discounts ($1,458,243 for six months), and it issued warrants totaling 43,907,807 shares, creating potential dilution. Management discloses substantial doubt about the company’s ability to continue as a going concern within one year and a Nasdaq minimum bid-price deficiency, with a compliance window available.
SCWorx Corp. Schedule 13G/A discloses that Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page report beneficial interests in the issuer through outstanding warrants and convertible notes. The filing shows reported aggregates of 403,850 shares for Richard Abbe (reported as 9.99% of the class) and 305,524 shares for each of Iroquois Capital and Kimberly Page (reported as 7.75% of the class). These reported amounts include shares issuable upon conversion/exercise but are limited by contractual Beneficial Ownership Blockers that restrict conversion/exercise to 4.99% or 9.99% thresholds, so all instruments could not be converted or exercised as reported. Some Convertible Notes convert at a stated conversion price of $0.3496. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest and certify the securities were not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of Scworx (WORX)?
What is the market cap of Scworx (WORX)?
